Literature DB >> 23010140

Inactivation of the glutamine/amino acid transporter ASCT2 by 1,2,3-dithiazoles: proteoliposomes as a tool to gain insights in the molecular mechanism of action and of antitumor activity.

Francesca Oppedisano1, Marco Catto, Panayiotis A Koutentis, Orazio Nicolotti, Lorena Pochini, Maria Koyioni, Antonellina Introcaso, Sophia S Michaelidou, Angelo Carotti, Cesare Indiveri.   

Abstract

The ASCT2 transport system catalyses a sodium-dependent antiport of glutamine and other neutral amino acids which is involved in amino acid metabolism. A library of 1,2,3-dithiazoles was designed, synthesized and evaluated as inhibitors of the glutamine/amino acid ASCT2 transporter in the model system of proteoliposomes reconstituted with the rat liver transporter. Fifteen of the tested compounds at concentration of 20μM or below, inhibited more than 50% the glutamine/glutamine antiport catalysed by the reconstituted transporter. These good inhibitors bear a phenyl ring with electron withdrawing substituents. The inhibition was reversed by 1,4-dithioerythritol indicating that the effect was likely owed to the formation of mixed sulfides with the protein's Cys residue(s). A dose-response analysis of the most active compounds gave IC(50) values in the range of 3-30μM. Kinetic inhibition studies indicated a non-competitive inhibition, presumably because of a potential covalent interaction of the dithiazoles with cysteine thiol groups that are not located at the substrate binding site. Indeed, computational studies using a homology structural model of ASCT2 transporter, suggested as possible binding targets, Cys-207 or Cys-210, that belong to the CXXC motif of the protein.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23010140     DOI: 10.1016/j.taap.2012.09.011

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  18 in total

1.  Clinical significance of coexpression of L-type amino acid transporter 1 (LAT1) and ASC amino acid transporter 2 (ASCT2) in lung adenocarcinoma.

Authors:  Tomohiro Yazawa; Kimihiro Shimizu; Kyoichi Kaira; Toshiteru Nagashima; Yoichi Ohtaki; Jun Atsumi; Kai Obayashi; Shushi Nagamori; Yoshikatsu Kanai; Tetsunari Oyama; Izumi Takeyoshi
Journal:  Am J Transl Res       Date:  2015-06-15       Impact factor: 4.060

2.  2-Amino-4-bis(aryloxybenzyl)aminobutanoic acids: A novel scaffold for inhibition of ASCT2-mediated glutamine transport.

Authors:  Michael L Schulte; Alexandra B Khodadadi; Madison L Cuthbertson; Jarrod A Smith; H Charles Manning
Journal:  Bioorg Med Chem Lett       Date:  2015-12-11       Impact factor: 2.823

Review 3.  Advances and Challenges in Rational Drug Design for SLCs.

Authors:  Rachel-Ann A Garibsingh; Avner Schlessinger
Journal:  Trends Pharmacol Sci       Date:  2019-09-10       Impact factor: 14.819

Review 4.  The role of the glutamine transporter ASCT2 in antineoplastic therapy.

Authors:  Estefânia Teixeira; Cláudia Silva; Fátima Martel
Journal:  Cancer Chemother Pharmacol       Date:  2021-01-19       Impact factor: 3.333

Review 5.  Membrane transporters for the special amino acid glutamine: structure/function relationships and relevance to human health.

Authors:  Lorena Pochini; Mariafrancesca Scalise; Michele Galluccio; Cesare Indiveri
Journal:  Front Chem       Date:  2014-08-11       Impact factor: 5.221

6.  Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer.

Authors:  M Toyoda; K Kaira; Y Ohshima; N S Ishioka; M Shino; K Sakakura; Y Takayasu; K Takahashi; H Tominaga; N Oriuchi; S Nagamori; Y Kanai; T Oyama; K Chikamatsu
Journal:  Br J Cancer       Date:  2014-04-24       Impact factor: 7.640

7.  Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour development.

Authors:  Qian Wang; Rae-Anne Hardie; Andrew J Hoy; Michelle van Geldermalsen; Dadi Gao; Ladan Fazli; Martin C Sadowski; Seher Balaban; Mark Schreuder; Rajini Nagarajah; Justin J-L Wong; Cynthia Metierre; Natalia Pinello; Nicholas J Otte; Melanie L Lehman; Martin Gleave; Colleen C Nelson; Charles G Bailey; William Ritchie; John E J Rasko; Jeff Holst
Journal:  J Pathol       Date:  2015-04-07       Impact factor: 7.996

8.  Interaction of the neutral amino acid transporter ASCT2 with basic amino acids.

Authors:  Elias Ndaru; Rachel-Ann A Garibsingh; Laura Zielewicz; Avner Schlessinger; Christof Grewer
Journal:  Biochem J       Date:  2020-04-30       Impact factor: 3.766

9.  Proteoliposomes as tool for assaying membrane transporter functions and interactions with xenobiotics.

Authors:  Mariafrancesca Scalise; Lorena Pochini; Nicola Giangregorio; Annamaria Tonazzi; Cesare Indiveri
Journal:  Pharmaceutics       Date:  2013-09-18       Impact factor: 6.321

Review 10.  Glutamine Transport and Mitochondrial Metabolism in Cancer Cell Growth.

Authors:  Mariafrancesca Scalise; Lorena Pochini; Michele Galluccio; Lara Console; Cesare Indiveri
Journal:  Front Oncol       Date:  2017-12-11       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.